Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5489364> ?p ?o }
Showing triples 1 to 68 of
68
with 100 triples per page.
- Q5489364 description "British neuroscientist".
- Q5489364 description "British neuroscientist".
- Q5489364 subject Q5312304.
- Q5489364 subject Q6647483.
- Q5489364 subject Q6999066.
- Q5489364 subject Q7885244.
- Q5489364 subject Q8445762.
- Q5489364 subject Q8445849.
- Q5489364 subject Q8754010.
- Q5489364 subject Q8882790.
- Q5489364 subject Q8974785.
- Q5489364 subject Q9408041.
- Q5489364 abstract "Frank S. Walsh PhD, DSc (Hon.) FMedSci, FKC, corrFRSE (born 1953 in Wishaw, North Lanarkshire) is a British-born neuroscientist. He is best known for his work on the understanding of the role of cell adhesion molecules in the development and regeneration of the nervous system. He is the author of over 250 publications in peer-reviewed journals.In 2008 he was made a Corresponding Fellow of the Royal Society of Edinburgh]], and in 2007 became a Fellow of King's College London. He has also received honorary degrees from the Universities of Perugia and Bologna in Italy, and the University of Strathclyde and University of Dundee in Scotland.Walsh started his scientific career with an undergraduate degree in biochemistry from the University of Strathclyde (1974)and a subsequent PhD in biochemistry from University College London with the research being carried out at the MRC National Institute for Medical Research(1977). His post-doctoral training was conducted under the tutelage of the Nobel prize winner Marshall Nirenberg at the NIH in [[Bethesda, Maryland] USA] (1977-79).From 2002 - 2009 he was Executive Vice President of Discovery Research at Wyeth, a leading pharmaceutical company in Collegeville Pennsylvania, USA. In this role he has been responsible for overseeing the transition of more than 80 novel drug candidates into clinical development for a number of devastating diseases such as Alzheimer's disease, stroke, schizophrenia, cancer, diabetes, osteoarthritis, rheumatoid arthritis and COPD.In 2012 he formed a new Biotechnology company called Ossianix to develop biological therapeutics for serious diseases of the brain and other organ systems. www.ossianix.com. The company is based in Philadelphia USA and Stevenage UK.He was Sir William Dunn Professor and Head of Experimental Pathology at the United Medical and Dental Schools from 1989, and Research Dean from 1994 until 1997 when he joined SmithKline Beecham as Vice President of Neuroscience Research. With the creation of GlaxoSmithKline from the merger of SmithKline Beecham and Glaxo Wellcome, he became Senior Vice President and Head of the company's Neurology-Centre of Excellence for Drug Discovery.In addition to his corporate roles, he holds Visiting Professorships at King's College London, the University College Dublin, and was elected to the Academy of Medical Sciences (London) in 2003. In addition, he has been chairman of the Muscular Dystrophy Campaign research committee, a Trustee of Spinal Research, a visiting examiner at King's College London, an adviser to the college's MRC Centre for Developmental Neurobiology and a special advisor to the Wolfson Centre for Age-Related Diseases. He was also joint Editor-in-Chief of the journal Molecular and Cellular Neuroscience.".
- Q5489364 birthDate "1953".
- Q5489364 birthYear "1953".
- Q5489364 wikiPageWikiLink Q1068258.
- Q5489364 wikiPageWikiLink Q110060.
- Q5489364 wikiPageWikiLink Q11081.
- Q5489364 wikiPageWikiLink Q1137767.
- Q5489364 wikiPageWikiLink Q12206.
- Q5489364 wikiPageWikiLink Q1859178.
- Q5489364 wikiPageWikiLink Q187255.
- Q5489364 wikiPageWikiLink Q187637.
- Q5489364 wikiPageWikiLink Q1891.
- Q5489364 wikiPageWikiLink Q199804.
- Q5489364 wikiPageWikiLink Q207011.
- Q5489364 wikiPageWikiLink Q207111.
- Q5489364 wikiPageWikiLink Q212322.
- Q5489364 wikiPageWikiLink Q2305226.
- Q5489364 wikiPageWikiLink Q245247.
- Q5489364 wikiPageWikiLink Q3437.
- Q5489364 wikiPageWikiLink Q390551.
- Q5489364 wikiPageWikiLink Q41112.
- Q5489364 wikiPageWikiLink Q4671486.
- Q5489364 wikiPageWikiLink Q5312304.
- Q5489364 wikiPageWikiLink Q62736.
- Q5489364 wikiPageWikiLink Q6337803.
- Q5489364 wikiPageWikiLink Q6647483.
- Q5489364 wikiPageWikiLink Q6895985.
- Q5489364 wikiPageWikiLink Q6999066.
- Q5489364 wikiPageWikiLink Q7094.
- Q5489364 wikiPageWikiLink Q746879.
- Q5489364 wikiPageWikiLink Q7885244.
- Q5489364 wikiPageWikiLink Q8445762.
- Q5489364 wikiPageWikiLink Q8445849.
- Q5489364 wikiPageWikiLink Q8754010.
- Q5489364 wikiPageWikiLink Q8882790.
- Q5489364 wikiPageWikiLink Q8974785.
- Q5489364 wikiPageWikiLink Q9404.
- Q5489364 wikiPageWikiLink Q9408041.
- Q5489364 dateOfBirth "1953".
- Q5489364 name "Walsh, Frank S".
- Q5489364 shortDescription "British neuroscientist".
- Q5489364 type Person.
- Q5489364 type Agent.
- Q5489364 type Person.
- Q5489364 type Agent.
- Q5489364 type NaturalPerson.
- Q5489364 type Thing.
- Q5489364 type Q215627.
- Q5489364 type Q5.
- Q5489364 type Person.
- Q5489364 comment "Frank S. Walsh PhD, DSc (Hon.) FMedSci, FKC, corrFRSE (born 1953 in Wishaw, North Lanarkshire) is a British-born neuroscientist. He is best known for his work on the understanding of the role of cell adhesion molecules in the development and regeneration of the nervous system. He is the author of over 250 publications in peer-reviewed journals.In 2008 he was made a Corresponding Fellow of the Royal Society of Edinburgh]], and in 2007 became a Fellow of King's College London.".
- Q5489364 label "Frank S. Walsh".
- Q5489364 givenName "Frank S".
- Q5489364 name "Frank S Walsh".
- Q5489364 name "Walsh, Frank S".
- Q5489364 surname "Walsh".